InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IZM | Ann: Suspension from Official Quotation | 15/09/15 | 7 | 2.7K | |||
|
|||||||
IZM | Ann: Supplementary Prospectus | 15/12/14 | 0 | 493 | |||
|
|||||||
IZM | Ann: Results of Meeting | 03/12/14 | 0 | 394 | |||
|
|||||||
IZM | Ann: Change in substantial holding | 28/11/14 | 0 | 362 | |||
|
|||||||
IZM | Ann: Results of Meeting | 27/11/14 | 0 | 352 | |||
|
|||||||
IZM | Ann: Ceasing to be a substantial holder | 26/11/14 | 0 | 322 | |||
|
|||||||
IZM | Ann: xTV Networks Ltd lodges Prospectus | 25/11/14 | 0 | 465 | |||
|
|||||||
IZM | Ann: Appendix 3B | 24/11/14 | 0 | 372 | |||
|
See All Discussions